Article

Image IQ: 62-Year-Old Diabetic with Persistent Rash

Check out this month's Image IQ from VisualDx. This month's quiz features a 62-year-old patient with type 2 diabetes and a persistent rash that was originally diagnosed as eczema.

Case Report:

A 62-year-old man with a long history of type 2 diabetes went to a dermatologist after a rash that had been diagnosed as eczema by his primary care doctor failed to resolve with treatment after nine months. In fact, it seemed to have worsened despite his careful adherence to treatment recommendations. The lesions developed first on his lower extremities but were now widespread and included his face and perianal region. The lesions were annular and sometimes serpiginous with crusting and distinctive borders with central clearing. The patient said the lesions could be quite itchy. Over the same period of time he had also noticed some weight loss and a few bouts of abdominal pain and diarrhea. Blood tests revealed mild anemia but were otherwise normal.

  1. Tinea corporis
  2. Subacute cutaneous lupus erythematosus
  3. Erythema gyratum repens
  4. Glucagonoma syndrome

Can you diagnose the patient? Use the Differential Builder in VisualDx to help you: https://bit.ly/37UIzJK

Learn more about this diagnosis on the VisualDx site: https://bit.ly/2BsVO8p

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Matthew J. Budoff, MD: Impact of Obesity on Cardiometabolic Health in T1D | Image Credit: The Lundquist Institute
Jennifer B. Green, MD: Implementation of Evidence-Based Therapies for T2D | Image Credit: Duke University
Ralph A. DeFronzo, MD: Noxious Nine and Mifepristone for Hypercortisolism in T2D | Image Credit: LinkedIn
Diabetes Dialogue: Diabetes Tech Updates from November 2024 | Image Credit: HCPLive
© 2024 MJH Life Sciences

All rights reserved.